KATHRYN E. FALBERG

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

aTYR PHARMA INC

Filing Date Source Excerpt
2016-04-12 Ms. Falberg holds a B.A. in economics and an M.B.A. in finance from UCLA. No mention of software or technical skills.
2017-03-30 Ms. Falberg holds a B.A. in economics and an M.B.A. in finance from the University of California, Los Angeles.

HALOZYME THERAPEUTICS, INC.

Filing Date Source Excerpt
2009-04-02 Ms. Falberg received an M.B.A. and B.A. in Economics from the University of California, Los Angeles.
2010-04-01 Ms. Falberg received an M.B.A. and B.A. in Economics from the University of California, Los Angeles. She contributes considerable healthcare industry knowledge, particularly in the areas of finance, accounting and operations.
2011-03-24 Ms. Falberg received an M.B.A. and B.A. in Economics from the University of California, Los Angeles.
2012-03-29 Ms. Falberg received an M.B.A. and B.A. in Economics from the University of California, Los Angeles and is a Certified Public Accountant.
2013-04-11 Ms. Falberg has served as Executive Vice President and Chief Financial Officer of Jazz Pharmaceuticals, Inc. and is a Certified Public Accountant.
2014-04-07 Ms. Falberg contributes considerable healthcare industry knowledge, particularly in the areas of finance, accounting, strategy, business development and operations. Ms. Falberg received an M.B.A. and B.A. in Economics from the University of California, Los Angeles and is a Certified Public Accountant.
2015-04-03 Ms. Falberg received an M.B.A. and B.A. in Economics from the University of California, Los Angeles and is a Certified Public Accountant, inactive.
2016-03-23 Ms. Falberg contributes considerable healthcare industry knowledge to our Board, particularly in the areas of finance, accounting, strategy, business development and operations.

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22